Bustamante Carlos, Pinilla Laura, Amaris Oscar
Faculty of Medicine, National University of Colombia, Bogotá, Colombia.
Clin Med Insights Case Rep. 2023 Apr 5;16:11795476231159584. doi: 10.1177/11795476231159584. eCollection 2023.
It has been proposed that the immunomodulatory capacity of neuraltherapeutic medicine (NTM) functions by means of stimuli to the nervous system, which influences the self-regulatory and plastic capacity of the nervous system, especially through the autonomic balance between the sympathetic and parasympathetic nervous systems. Several studies report the usefulness of NTM in inflammatory pathologies.
A case report through a retrospective review of the medical history of an 82-year-old male patient with a diagnosis of acute SARS-CoV-2 who received a therapeutic intervention of NTM at the beginning of his hospitalization and presented satisfactory clinical evolution, with a follow-up for 18 months without post-COVID sequelae. A patient diagnosed with acute pneumonia for SARS-CoV-2, and mild ARDS, with markers of severity given by the history of COPD, advanced age, and elevation of LDH, ferritin, and CRP. On the third day of hospitalization, he presented an episode of pulmonary thromboembolism. He presented significant clinical improvement with in-hospital management for 9 days and underwent out-patient control with no post-COVID sequelae.
NTM could be useful for the management of acute inflammatory diseases, including viral diseases such as SARS-CoV-2, in a mild or severe state of inflammation, when added to allopathic medicine, and it can improve clinical evolution and long-term sequelae. More studies are needed to validate this information.
有人提出，神经治疗药物（NTM）的免疫调节能力是通过刺激神经系统来发挥作用的，这会影响神经系统的自我调节和可塑性，尤其是通过交感神经系统和副交感神经系统之间的自主平衡。多项研究报告了NTM在炎症性疾病中的有效性。
通过回顾一名82岁男性患者的病史进行病例报告，该患者被诊断为急性SARS-CoV-2感染，在住院初期接受了NTM治疗干预，临床进展令人满意，随访18个月无新冠后遗症。一名被诊断为SARS-CoV-2引起的急性肺炎和轻度急性呼吸窘迫综合征的患者，其严重程度指标包括慢性阻塞性肺疾病病史、高龄以及乳酸脱氢酶、铁蛋白和C反应蛋白升高。在第三天，他出现了一次肺血栓栓塞事件。经过9天的住院治疗，他的临床症状有了显著改善，并接受了门诊检查，无新冠后遗症。
当与传统医学药物联合使用时，NTM可能有助于治疗急性炎症性疾病，包括处于轻度或重度炎症状态的病毒性疾病，如SARS-CoV-2，并且可以改善临床进展和长期后遗症。需要更多研究来验证这一信息。
